Combining Language Therapy With rTMS in Aphasia (ILAT+rTMS)

August 12, 2018 updated by: Paula Heikkinen

Combining Language Therapy With rTMS in Chronic Stage of Aphasia: A Randomized Controlled Trial

With the present RCT, the investigators aimed at finding an optimal protocol for the neurorehabilitation of chronic post-stroke aphasia by combining two promising methods, ILAT (Intensive language action therapy) and 1-Hz rTMS to the right-hemispheric homologue of the anterior language area of Broca (pars triangularis), thus taking advantage of recent research in speech and language sciences, neurorehabilitation and brain research.

Study Overview

Detailed Description

New neuromodulation technologies, such as transcranial magnetic stimulation (TMS), are promising tools for neurorehabilitation, aphasia therapy included. Combined with behavioral techniques, Intensive Language-Action Therapy (ILAT), TMS could substantially amplify the beneficial effect of such behavioral therapy alone.

In this randomized study of 17 subjects with post-stroke aphasia in the chronic stage will be studied the combined effect of ILAT and 1-Hz placebo-controlled navigated repetitive TMS (rTMS) to the right-hemispheric inferior frontal cortex (pars triangularis). Participant will be randomized to groups A and B. Participants in group A will receive a 2-week period of rTMS during naming training where they name pictures every ten second displayed on the screen, followed by 2-weeks of rTMS and naming combined with ILAT. Those in group B will receive the same behavioral therapy but TMS is replaced by sham stimulation.

Language performance will be measured before, during and after the interventions for 3 months.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 18 and 75 years
  • presence of a single clinically documented stroke
  • chronic stage (at least 12 months post-stroke)
  • aphasia documented using the WAB test
  • no recurring utterances or severe global (total) aphasia
  • residual ability to understand simple task instructions
  • availability of information about medication
  • right-handedness
  • native speakers of Finnish.

Exclusion Criteria:

  • severe global (total) aphasia (Boston naming test less 3 points)
  • neglect, agnosia, severe vision impairment or hearing loss
  • severe attention or memory deficits
  • left-handedness
  • cardiac pacemaker or other stimulators
  • diagnosis of severe diabetes or severe depression
  • additional neurological diagnoses
  • other interventions, including speech therapy, in the same time period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: rTMS and naming combined with ILAT
Interventions: Repetitive navigated Transcranial Magnetic Stimulation, picture naming and Intensive Language Action Therapy
ILAT includes communicative language games played in an interactive small-group setting. Three persons with aphasia and one therapist sit around a table and have picture cards in front of them. The card sets include two items of each object or action picture. All participants take turns in making verbal requests. There will be 5 daily sessions (3 hours per session) for two weeks.
Magnetic stimulation will delivered with a figure-of-eight cooled coil of Navigated Brain Stimulation System during picture naming training. The primary targeted area is the right pars triangularis. In each session, rTMS will be applied at 1-Hz for 20 minutes, 5 daily sessions per week for four weeks.
Sham Comparator: sham rTMS and naming combined with ILAT
Interventions: sham Repetitive navigated Transcranial Magnetic Stimulation, picture naming and Intensive Language Action Therapy
ILAT includes communicative language games played in an interactive small-group setting. Three persons with aphasia and one therapist sit around a table and have picture cards in front of them. The card sets include two items of each object or action picture. All participants take turns in making verbal requests. There will be 5 daily sessions (3 hours per session) for two weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Western Aphasia Battery
Time Frame: Change in AQ performed at weeks 1 (baseline), 4 and 7 and follow up 3 months after therapy completion
aphasia quotient (AQ) measurement
Change in AQ performed at weeks 1 (baseline), 4 and 7 and follow up 3 months after therapy completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Boston naming test
Time Frame: Change in picture naming ability between weeks 1 (baseline), 4 and 7 and follow up 3 months after therapy completion
picture naming ability
Change in picture naming ability between weeks 1 (baseline), 4 and 7 and follow up 3 months after therapy completion
The Action naming test
Time Frame: Change in picture naming ability between weeks 1 (baseline), 4 and 7 and follow up 3 months after therapy completion
picture naming ability
Change in picture naming ability between weeks 1 (baseline), 4 and 7 and follow up 3 months after therapy completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Anu Klippi, Professor, University of Helsinki
  • Study Chair: Jyrki Mäkelä, MD, BioMag Laboratory, Helsinki University Hospital
  • Study Chair: Friedemann Pulvermüller, Professor, Brain Language Laboratory, Department of Philosophy and Humanities, WE4, Freie Universität Berlin
  • Study Chair: Risto Ilmoniemi, Professor, Department of Neuroscience and Biomedical Engineering, Aalto University School of Science

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2012

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

July 31, 2018

First Submitted That Met QC Criteria

August 12, 2018

First Posted (Actual)

August 14, 2018

Study Record Updates

Last Update Posted (Actual)

August 14, 2018

Last Update Submitted That Met QC Criteria

August 12, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphasia

Clinical Trials on Intensive Language-Action Therapy (ILAT)

3
Subscribe